Month: September 2016

Bedfont® Scientific, based in Maidstone, Kent, encourages people to quit smoking this Stoptober for the chance to win £100 worth of amazon vouchers.

October has become the ideal time for people to quit since Public Health England introduced the 28-day stop smoking challenge known as Stoptober. Last year a record 215,000 people signed up to Stoptober, however, despite the huge interest, recent statistics from ASH show that there are still around 9.6 million adult smokers in Great Britain alone. Bedfont Scientific, manufacturer of the Smokerlyzer® which is used to help people quit smoking, is encouraging people to quit this Stoptober and have their photo taken with the Smokerlyzer®, showing their “green light” photo and use the hashtag #Stoptober for a chance to win £100 in amazon vouchers.

The Smokerlyzer® range is a series of breath carbon monoxide (CO) monitors that measure the harmful amount of CO that is inhaled from smoking, which can show how much a patient has been smoking, giving smoking cessation advisors an idea on the level of dependency that the smoker has. The Smokerlyzer® is quick, non-invasive and also acts as a motivational visual aid with its traffic light system, to encourage the user to quit smoking and to measure their progress whilst doing so.

Bedfont Scientific are celebrating 40 years in business this year and are revered as pioneers in the breath analysis market. Founder, Trevor Smith, created the Smokerlyzer® in 1985, which is also celebrating its 30th birthday in 2016. With over 520,000 units sold since existence, the Smokerlyzer® is one of Bedfont’s most successful exports and can now be found in over 70 countries across the world.

Jason Smith, General Manager at Bedfont Scientific, says, “Every year, around 96,000 people in the UK die from diseases caused by smoking, but the Smokerlyzer® can help people quit and save their lives. Last Stoptober we were amazed at the number of people who quit smoking and proud that our Smokerlyzer® was used to help them. We want to hear the stories of how the Smokerlyzer® is changing people’s lives and encourage more people to quit smoking this year, and so we are holding a competition. For those who wish to quit smoking and enter the competition, simply visit your local stop smoking service for help and send us your “green-light” photos; we will be putting them into a prize draw to win £100 in amazon vouchers.”

For more information on Bedfont’s #Stoptober competition, please visit www.bedfont.com/30yearsofsmokerlyzer.

Bedfont® Scientific, Kent, launches their new GastroCH4ECK™ Gastrolyzer®  at the United European Gastroenterology Week 2016

Bedfont® Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976. With an unprecedented network of distributors, Bedfont’s products can be found in over 70 countries worldwide.

At the United European Gastroenterology Week (UEGW) 2016, Bedfont can be found at booth X1/5, introducing the new and improved GastroCH4ECK™ Gastrolyzer®, a breath hydrogen and methane analyser used to help detect gastrointestinal disorders.

The GastroCH4ECK™ Gastrolyzer® helps to detect gastrointestinal disorders such as IBS, SIBO and sugar intolerances such as lactose intolerance. This is done by measuring the amount of hydrogen and methane in a patient’s breath, which is produced by the breakdown of food in the gut.

Dr Anthony Hobson, the Clinical Director of the Functional Gut Clinic, explains,

“As an existing customer of the Gastrolyzer® range, I am delighted to have had the chance to test the unit before anyone else, and can truly say that the new sensor technology and friendly user interface make this the best hydrogen and methane breath test available, thanks to improved accuracy and ease of use. The GastroCH4ECK™ is the only hydrogen and methane breath testing monitor that offers direct breath samples meaning I can see my patients quicker and more efficiently, allowing me to provide a Gold Standard breath testing service.”

Jason Smith, General Manager at Bedfont Scientific, comments,

“The GastroCH4ECK™ Gastrolyzer® is simple to use for both patient and Doctor. It is completely non-invasive, making it the preferred method for patients who do not wish to provide a blood sample but also gives an instant reading, compared to having to wait up to two weeks for the blood sample to be tested, meaning the patient suffers less. We are proud to be unveiling our new GastroCH4ECK™ Gastrolyzer® at UEGW 2016 and hope that all who specialise in gastroenterology will come and see our new and improved monitor.”

Bedfont Scientific, medical device manufacturer in Maidstone, Kent, is proud to be supplying Laborie, as it lands another major OEM deal, opening up more overseas markets.

LABORIE, an international leader in medical devices but notably gastroenterology, has signed an OEM agreement with Bedfont Scientific for their Gastrolyzer range of hydrogen and methane breath monitors.

The Gastrolyzer range offers a quicker, more efficient, and non-invasive method to investigating and detecting gastrointestinal disorders compared to more traditional methods which can take up to two weeks to diagnose and require a blood sample.

Albert Meek, LABORIE General Manager, GI Solutions, comments,

“Breath analysis is such an innovative leap in medical technology, saving specialists and patients’ time and hassle. The Gastrolyzer range of high-quality hydrogen and methane breath monitors will enable us to further deliver Gastroenterological solutions that advance diagnostic confidence and transform the treatment of care.”

Bedfont, who in 2016 are celebrating two important anniversaries – 40 years in business and 30 years of one of their most successful exports – the Smokerlyzer, are revered as pioneers in breath analysis thanks to their unprecedented network of appointed distributors.  This major OEM deal comes shortly after Bedfont recently agreed another OEM deal with Global Medicare for the Gastrolyzer range exclusively in India.

Jason Smith, General Manager at Bedfont Scientific, says,

“These OEMs are part of our expansion plan for our core breath business. The aim is to make breath analysis global and easily accessible, allowing more people to be diagnosed by a faster, more efficient and non-invasive method. Thanks to LABORIE, breath analysis will now be available in medical markets worldwide that Bedfont did not have access to before.”